Last reviewed · How we verify
Control/Placebo group — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Control/Placebo group (Control/Placebo group) — University of Virginia. A control or placebo group receives no active intervention and serves as a comparator to measure the efficacy and safety of an investigational drug.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Control/Placebo group TARGET | Control/Placebo group | University of Virginia | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Control/Placebo group CI watch — RSS
- Control/Placebo group CI watch — Atom
- Control/Placebo group CI watch — JSON
- Control/Placebo group alone — RSS
Cite this brief
Drug Landscape (2026). Control/Placebo group — Competitive Intelligence Brief. https://druglandscape.com/ci/control-placebo-group. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab